MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Retrospective review of MRI-guided focused ultrasound (MRgFUS) thalamotomy referrals: updated experience from a single movement disorder center

    E. Einstein, L. Pan, A. Mogilner (New York, USA)

    Objective: To evaluate referrals for MRI-guided focused ultrasound (MRgFUS) in terms of patient characteristics, reasons for referral, and decision outcomes. Background: Transcranial MRI-guided focused ultrasound…
  • MDS Virtual Congress 2021

    Effect of deep brain stimulation on quality of life of patients with Parkinson’s Disease

    V. Junior, I. Andrade, L. Castanheira, B. Orleans, F. da Silva, L. Magalhães (Salvador, Brazil)

    Objective: Analyze the effects of DBS on the quality of life of patients diagnosed with Parkinson's disease. Background: Parkinson's disease is a neurodegenerative syndrome due…
  • MDS Virtual Congress 2021

    The feasibility and efficacy of virtual visits compared to in-person visits for follow up in Parkinson´s disease: methodology for an international, multicenter trial (NCT04695353).

    JH. Ahn, J. Youn, O. Ojo, N. Okubadejo, A. Shalash, A. Cardozo, Z. Aldaajani, J. Bajwa, M. Dekker, á. Bustillo, E. Eldayem, M. Shackleford, M. Spindler, Z. Mari, E. Cubo (Seoul, Republic of Korea)

    Objective: To investigate the feasibility and efficacy of virtual visits for Parkinson Disease (PD) compared to in-person visits. Background: Considering limited access to specialists for…
  • MDS Virtual Congress 2021

    Technology use in Parkinson’s disease and parkinsonism: a multicenter survey in real-life Healthy East Lombardy Parkinson (HELP-)network

    A. Pilotto, S. Nocivelli, D. Alimenti, J. Melgari, M. Bianchi, V. de Giuli, A. Magherini, M. Rizzeti, F. Pisano, T. Di Monda, M. Gennuso, S. Gipponi, E. Cottini, A. Imarisio, S. Masciocchi, B. Bagni, E. Magni, M. Sessa, M. Turla, B. Ferraro, P. Trippa, A. Prelle, A. Ciccone, A. Padovani (Brescia, Italy)

    Objective: to evaluate the real-life use of internet and technological devices in parkinsonian patients Background: technology use is increasing in the ageing population but no…
  • MDS Virtual Congress 2021

    The course of tremor in de novo PD: 7 year longitudinal analysis

    J. Pasquini, N. Pavese (Milano, Italy)

    Objective: To longitudinally describe the course and clinical characteristics of tremor in Parkinson Disease (PD) over a seven-year follow up. Background: Tremor is a cardinal…
  • MDS Virtual Congress 2021

    Distinct impulsive traits in cerebellar ataxia and Parkinson’s disease

    T. Chen, C. Lin, M. Aumann, D. Claassen, S. Kuo (New York, USA)

    Objective: To determine the differences in impulsive personality traits between patients with cerebellar ataxia (CA) and Parkinson’s disease (PD). Background: Impulsivity is a multifaceted construct…
  • MDS Virtual Congress 2021

    Prevalence of Parkinsonism and Parkinson Disease in urban and rural populations in Latin America.

    J. Llibre-Guerra, M. Prina, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, A. Rodriguez-Salgado, J. Llibre-Guerra, G. Peters, I. Acosta, J. Juncos, J. Llibre-Rodriguez (La Habana, Cuba)

    Objective: To estimate the prevalence and risk factors of parkinsonism and Parkinson Disease in elderly individuals from Latin America. Background: Parkinson’ s disease (PD) is…
  • MDS Virtual Congress 2021

    Tinospora Cordifolia protects against Rotenone induced degeneration of dopaminergic neurons in mouse model of Parkinson’s disease

    S. Singh, H. Birla (Varanasi, India)

    Objective: To explore the neuroprotective mechanisms of T. cordifolia ethanolic extract against Rotenone (ROT)-intoxicated mouse model through proteomics approach. Background: The death of dopaminergic (DAergic)…
  • MDS Virtual Congress 2021

    Alpha-synuclein oligomers detection by proximity ligation assay in skin biopsy is a biomarker for Parkinson’s disease

    E. Vacchi, C. Senese, S. Pinton, A. Kaelin-Lang, G. Melli (Lugano, Switzerland)

    Objective: To assess the presence of oligomeric alpha-synuclein (αSyn), an early pathogenic species, in skin nerve fibers of patients with Parkinson’s disease (PD) and atypical…
  • MDS Virtual Congress 2021

    Pharmacokinetic–pharmacodynamics of levodopa/carbidopa following subcutaneous infusion with ND0612: Results from the BeyoND pharmacokinetic substudy

    T. Birnberg, L. Adar, W. Poewe, M. Bjornsson, M. Karlsson (Rehovot, Israel)

    Objective: To evaluate the pharmacokinetic–pharmacodynamic relationships between levodopa plasma exposure and motor treatment response in patients with Parkinson’s disease (PD) treated with ND0612 and adjunct…
  • « Previous Page
  • 1
  • …
  • 539
  • 540
  • 541
  • 542
  • 543
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley